Sagimet Biosciences Inc. (SGMT)

NASDAQ: SGMT · Real-Time Price · USD

10.55

+1.27 (13.69%)

At close: Aug 14, 2026, 4:00 PM EDT

10.45

-0.11 (-1.00%)

After-hours: Aug 14, 2026, 4:24 PM EDT

Sagimet Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	165.9	35.02	75.84	75.14	0.16	56.73
Short-Term Investments	74.23	78.1	75.41	19.76	32.19	-
Cash & Short-Term Investments	240.13	113.12	151.25	94.9	32.35	56.73
Cash Growth	91.48%	-25.21%	59.38%	193.39%	-42.98%	-17.42%
Prepaid Expenses	3.2	2.8	1.06	1.35	0.41	0.42
Other Current Assets	0.66	0.48	0.46	0.4	0.03	1.51
Total Current Assets	243.99	116.4	152.77	96.65	32.79	58.66
Property, Plant & Equipment	1.95	0.08	0.08	0.07	0.21	0.34
Long-Term Investments	17.44	-	7.41	-	-	-
Other Long-Term Assets	0.06	-	-	-	0.03	0.03
Total Assets	263.43	116.48	160.26	96.72	33.03	59.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.13	1.31	1.43	0.19	1.13	0.76
Accrued Expenses	4.18	3.69	2.95	4.85	3.96	1.32
Current Portion of Leases	0.08	0.08	0.08	0.07	0.13	0.12
Other Current Liabilities	0.03	0.03	0.01	0.56	0.06	0.24
Total Current Liabilities	5.42	5.1	4.45	5.65	5.28	2.44
Long-Term Leases	1.86	-	-	-	0.08	0.22
Other Long-Term Liabilities	-	-	-	-	0	-
Total Liabilities	7.28	5.1	4.45	5.65	5.36	2.66

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0	0	0	0	0
Additional Paid-In Capital	627.18	457.61	450.88	340.78	35	33.11
Retained Earnings	-370.95	-346.35	-295.31	-249.74	-221.87	-191.37
Comprehensive Income & Other	-0.08	0.12	0.23	0.03	-0.08	-
Total Common Equity	256.16	111.38	155.81	91.07	-186.95	-158.26
Shareholders' Equity	256.16	111.38	155.81	91.07	27.67	56.37
Total Liabilities & Equity	263.43	116.48	160.26	96.72	33.03	59.03

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.94	0.08	0.08	0.07	0.21	0.35
Net Cash (Debt)	255.62	113.05	158.58	94.83	32.13	56.38
Net Cash Growth	88.91%	-28.71%	67.22%	195.11%	-43.01%	-17.68%
Net Cash Per Share	6.78	3.49	5.06	9.07	174.06	459.97
Filing Date Shares Outstanding	62.16	32.59	32.2	31.91	22.9	0.12
Total Common Shares Outstanding	61.78	32.52	32.2	22.9	0.19	0.12
Working Capital	238.57	111.3	148.32	90.99	27.51	56.22
Book Value Per Share	4.15	3.42	4.84	3.98	-1010.08	-1291.08
Tangible Book Value	256.16	111.38	155.81	91.07	-186.95	-158.26
Tangible Book Value Per Share	4.15	3.42	4.84	3.98	-1010.08	-1291.08

SEC Filings: 10-K · 10-Q